Academic Surgical Unit, Centre for Digestive Disease, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Ann Surg. 2012 Apr;255(4):643-9. doi: 10.1097/SLA.0b013e318247d49f.
Prospective randomized double-blind placebo-controlled crossover trial of 14 female patients (median age 52 [30-69] years) with proctographically defined evacuatory dysfunction (ED) and demonstrable rectal hyposensitivity (elevated thresholds to balloon distension in comparison with age- and sex-matched controls).
Sacral nerve stimulation (SNS) is an evolving treatment for constipation. However, variable outcomes might be improved by better patient selection. Evidence that the effect of SNS may be mediated by modulation of afferent signaling promotes a role in patients with ED associated with rectal hyposensation.
SNS was performed by the standard 2-stage technique (temporary then permanent implantation). During a 4-week period of temporary stimulation, patients were randomized ON-OFF/OFF-ON for two 2-week periods. Before insertion (PRE), and during each crossover period, primary (rectal sensory thresholds) and secondary (bowel diaries, constipation, and GIQoL [gastrointestinal quality of life] scores) outcome variables were blindly assessed.
Thirteen patients completed the trial. Following stimulation, defecatory desire volumes to rectal balloon distension were normalized in 10 of 13 patients (PRE: mean 277 mL [234-320] vs ON: 163 mL [133-193] vs OFF: 220 mL [183-257 mL]; P = 0.006) and maximum tolerable volume in 9 of 13 (PRE: mean 350 mL [323-377] vs ON: 262 mL [219-305] vs OFF: 298 mL [256-340 mL]; P = 0.012). There was a significant increase in the percentage of successful bowel movements (PRE: median 43% [0-100] vs ON: 89% [11-100] vs OFF: 83% [11-100]; P = 0.007) and Wexner constipation scores improved (PRE: median 19 [9-26] vs ON: 10 [6-27] vs OFF: 13 [5-29]; P = 0.01). There were no significant changes in disease-specific or generic quality of life measures. Eleven patients progressed to permanent stimulation (9/11 success at 19 months).
Most patients with chronic constipation secondary to ED with rectal hyposensitivity responded to temporary SNS. The physiological results presented support a mechanistic role for rectal afferent modulation.
对 14 名女性患者(中位年龄 52 [30-69] 岁)进行前瞻性随机双盲安慰剂对照交叉试验,这些患者直肠出口梗阻(ED)和直肠感觉迟钝(与年龄和性别匹配的对照组相比,球囊扩张的直肠感觉阈值升高)通过直肠肛门测压术定义。
骶神经刺激(SNS)是治疗便秘的一种不断发展的方法。然而,通过更好的患者选择,可能会改善可变的结果。SNS 效应可能通过调节传入信号来介导的证据,这促进了与直肠感觉迟钝相关的 ED 患者的作用。
通过标准的 2 阶段技术(临时然后永久植入)进行 SNS。在为期 4 周的临时刺激期间,患者被随机分为 ON-OFF/OFF-ON 进行两个为期 2 周的交叉期。在插入前(PRE)和每个交叉期期间,盲法评估主要(直肠感觉阈值)和次要(排便日记、便秘和 GIQL [胃肠道生活质量]评分)结局变量。
13 名患者完成了试验。刺激后,13 名患者中的 10 名(PRE:平均 277 毫升[234-320] vs ON:163 毫升[133-193] vs OFF:220 毫升[183-257 毫升])的直肠球囊扩张的排便欲望量正常化,最大耐受量 9 名患者(PRE:平均 350 毫升[323-377] vs ON:262 毫升[219-305] vs OFF:298 毫升[256-340 毫升];P=0.012)。成功排便的百分比显著增加(PRE:中位数 43%[0-100] vs ON:89%[11-100] vs OFF:83%[11-100];P=0.007),Wexner 便秘评分改善(PRE:中位数 19[9-26] vs ON:10[6-27] vs OFF:13[5-29];P=0.01)。疾病特异性或一般生活质量测量无显著变化。11 名患者进展为永久性刺激(11 名患者中有 9 名在 19 个月时成功)。
大多数因直肠感觉迟钝导致 ED 的慢性便秘患者对临时 SNS 有反应。提出的生理结果支持直肠传入调节的机制作用。